Laura Trutoiu, Queen's University

Research

Adeno-Associated Virus Creatine Creatine Transporter Focused Ultrasound

Latest funding

Optimizing dosage and CTA-Enabling Pre-clinical Gene Therapy Studies for Creatine Transporter Deficiency
CIHR · 2023 · Principal investigator

All 1 grants and awards

Optimizing dosage and CTA-Enabling Pre-clinical Gene Therapy Studies for Creatine Transporter Deficiency

Principal investigatorCIHR2023Op. Grant :Bringing Rare Disease Gene Therapies to Clinical Trial Readiness- LOI

Principal investigators: Walia, Jagdeep S; Trutoiu, Laura; Alkins, Ryan D

Keywords: Adeno-Associated Virus; Creatine; Creatine Transporter; Focused Ultrasound

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Adeno-Associated Virus Dear Professor Trutoiu, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on adeno-associated virus connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Optimizing dosage and CTA-Enabling Pre-clinical Gene Therapy Studies for Creatine Transporter Deficiency" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]